Mealey's (November 9, 2018, 11:35 AM EST) -- NEW YORK — Efforts by the makers of the nocturia drug Noctiva to block the release of the competing drug Nocdurna were unsuccessful on Nov. 8, when a New York federal judge denied a preliminary injunction in their patent dispute following a six-day hearing in October (Ferring B.V., et al. v. Serenity Pharmaceuticals LLC, et al., No. 17-9922, S.D. N.Y., 2018 U.S. Dist. LEXIS 191472)....